Does Medicare Cover Ozempic, Wegovy & Zepbound? The 2026 GLP-1 Bridge, Explained
This is the question I get more than almost any other right now: "Will Medicare pay for my Ozempic?" or Wegovy, or Zepbound, or the new pills everyone's asking about. The honest answer has always been "it depends on why it's prescribed" — but as of July 1, 2026, that answer changed in a big way. There's now a brand-new program that, for the first time ever, lets some people on Medicare get these drugs for weight loss. Here's the whole picture in plain English.
First, the rule that's been true for years
GLP-1 drugs (that's the family Ozempic, Wegovy, Mounjaro, and Zepbound belong to) can cost $1,000 or more a month without coverage. Whether your Medicare drug plan (Part D) pays for them has always come down to a single thing: the medical reason on the prescription.
By law, standard Medicare Part D has never been allowed to cover a drug used only for weight loss. But the same drugs are approved to treat other conditions, and when they're prescribed for one of those, Part D can cover them like any other medication. So the same box of medicine might be covered for your neighbor and not for you — because of the diagnosis behind it.
When Medicare covers each drug (the medical-condition path)
Here's how the most common GLP-1 drugs line up under a normal 2026 Part D plan. In every case below, coverage still depends on your specific plan's formulary and rules, but this is the general picture:
| Drug | Covered by Part D when prescribed for… | Not covered for |
|---|---|---|
| Ozempic | Type 2 diabetes | Weight loss |
| Mounjaro | Type 2 diabetes | Weight loss |
| Wegovy | Reducing heart attack/stroke risk in people with heart disease and obesity | Weight loss alone |
| Zepbound | Moderate-to-severe obstructive sleep apnea in adults with obesity | Weight loss alone |
Notice the pattern: Ozempic and Mounjaro are diabetes drugs, so Medicare covers them for diabetes. Wegovy and Zepbound are the "weight" versions of the same medicines, but the FDA has approved them for specific medical problems too (heart-attack prevention, sleep apnea), and Medicare can cover them for those uses. What Medicare wouldn't touch, until now, was a prescription that simply said "for weight loss."
The big change: the Medicare GLP-1 Bridge (started July 1, 2026)
On July 1, 2026, Medicare launched a temporary program called the Medicare GLP-1 Bridge. For the first time, it lets eligible people on Medicare get certain GLP-1 drugs specifically for weight management — the exact use that was off-limits before — for a flat $50 copay per month.
It's called a "bridge" because it's a stopgap while Medicare studies how to handle these drugs long term. It runs through December 31, 2027. Three things make it unusual, and worth understanding before you get your hopes set on it:
Who qualifies for the $50 Bridge copay?
You first need to be enrolled in a Medicare drug plan — either a standalone Part D plan or a Medicare Advantage plan that includes drug coverage. From there, you have to meet one of these weight-and-health thresholds (BMI is a standard height-to-weight number your doctor can calculate in seconds):
- BMI of 35 or higher — no other condition required.
- BMI of 30 or higher plus heart failure, uncontrolled high blood pressure, or chronic kidney disease.
- BMI of 27 or higher plus prediabetes, a prior heart attack or stroke, or peripheral artery disease.
The medication also has to be prescribed for chronic weight management — not for diabetes. (If you have diabetes, your GLP-1 is likely covered the normal Part D way instead.)
How to actually get it
The Bridge doesn't work like a normal trip to the pharmacy. The paperwork runs through Medicare, not just your plan:
You can read the official details and check whether you might qualify at Medicare.gov/glp1bridge.
What this means for Kentuckians
If you've been paying full price for a weight-loss GLP-1 — or going without because the sticker price was impossible — the Bridge could take a $1,000-plus monthly cost down to $50. That's life-changing for a lot of people on a fixed income here in the Bluegrass.
But two cautions. First, the Bridge is temporary (through the end of 2027), so it's wise to talk with your doctor about a long-term plan, not just this window. Second, GLP-1 rules are changing faster than almost anything else in Medicare right now, and every drug plan handles the medical-condition path a little differently. If you're not sure which lane you fall into — covered for a condition, eligible for the Bridge, or neither — that's exactly the kind of thing worth a five-minute conversation before you assume the worst. For the rest of this year's updates, see 2026 Medicare Changes Every Kentuckian Should Know.
Common questions
Does Medicare cover Ozempic?
Medicare Part D covers Ozempic only when it's prescribed for type 2 diabetes, which is what the FDA approved it to treat. Medicare will not cover Ozempic when it's prescribed purely for weight loss, and Ozempic is not one of the drugs available through the new Medicare GLP-1 Bridge program.
Does Medicare cover Wegovy or Zepbound for weight loss?
Historically, no — federal law barred Medicare Part D from covering any drug used only for weight loss. That changed on July 1, 2026 with the Medicare GLP-1 Bridge, which lets eligible Part D members get Wegovy, Zepbound (KwikPen), or Foundayo for chronic weight management at a $50 copay per month. Wegovy and Zepbound may also be covered the normal way when prescribed for a covered medical condition such as heart disease or sleep apnea.
What is the Medicare GLP-1 Bridge program?
It's a temporary federal demonstration that runs from July 1, 2026 through December 31, 2027. It lets eligible Medicare Part D members fill Wegovy, Zepbound (KwikPen), or Foundayo for chronic weight management at a $50 copay for each 30-day supply, even though standard Part D still can't cover those drugs for weight loss alone.
Who qualifies for the $50 GLP-1 Bridge copay?
You must be enrolled in a Medicare drug plan and meet one of the weight-related criteria: a BMI of 35 or higher; a BMI of 30 or higher with heart failure, uncontrolled high blood pressure, or chronic kidney disease; or a BMI of 27 or higher with prediabetes, a prior heart attack or stroke, or peripheral artery disease. Your doctor also has to submit a prior authorization to Medicare's central processor.
Does the $50 copay count toward my $2,100 drug cap?
No. Because the Bridge is a separate program from your regular drug plan, the $50 copay does not count toward your Part D deductible or the $2,100 annual out-of-pocket cap, and Extra Help (the low-income subsidy) can't be applied to these Bridge drugs.
Not sure whether your GLP-1 is covered? You can get a free Medicare review. A local agent can check whether your drug is covered under your current plan, or whether the Bridge fits — free, and no pressure.
Quick recap
Test what you learned
Five quick questions — pick an answer to see if you're right, and why.
Want a straight answer for your situation?
I'm a local Kentucky agent. No call center, no pressure, no cost — just clear guidance on whether your medication is covered.
Or call me directly: (859) 618-6443
This article is general information, not medical or insurance advice for your specific situation, and program rules and figures change often. GLP-1 Bridge details, covered drugs, and eligibility are from CMS and are current as of July 2026; the program is a temporary demonstration and its terms may change. Whether any drug is covered depends on your plan's formulary, your prescription, and your doctor. Tyler Insurance Group is not connected with or endorsed by the U.S. government or the federal Medicare program. We do not offer every plan available in your area. For complete details, contact Medicare.gov or 1-800-MEDICARE.